S

SMMT

Summit Therapeutics Inc

13.35

Aug 14 • 3:59 PM ET -0.65 (-4.64%)

13.41

Aftermarket • 7:49 PM ET +0.06 (0.41%)

Healthcare Biotechnology USA Large NASD

Peers: EXEL REGN BMRN IONS MRNA VRTX ALNY INCY GILD AMGN

| Held by: XBI VTI VB VXF VBR IBB IWP IWR PINK IWF

Scroll to Statements

Index	-
Market Cap	10.65B
Enterprise Value	9.98B
Income	-856.09M
Sales	0.00M
Book/sh	0.79
Cash/sh	0.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	265
IPO	Mar 05, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	16.81
P/C	15.41
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	6.96
Current Ratio	6.96
Debt/Eq	0.03
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.12
EPS next Y	-1.15
EPS next Q	-0.29
EPS this Y	17.59%
EPS next Y	2.95%
EPS next 5Y	23.82%
EPS past 3/5Y	-52.45% -13.76%
Sales past 3/5Y	- -
EPS Y/Y TTM	-11.10%
Sales Y/Y TTM	-
EPS Q/Q	63.61%
Sales Q/Q	-
Earnings	Jul 23 AMC
EPS/Sales Surpr.	-2.04% -

Insider Own	83.15%
Insider Trans	1.20%
Inst Own	15.77%
Inst Trans	2.06%
ROA	-159.09%
ROE	-192.50%
ROIC	-132.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-3.50%
SMA50	-6.25%
SMA200	-20.25%
Trades

Shs Outstand	793.12M
Shs Float	134.39M
Short Float	26.97%
Short Ratio	7.20
Short Interest	36.25M
52W High	30.05 -55.57%
52W Low	12.25 8.98%
Volatility	6.46% 6.11%
ATR (14)	0.86
RSI (14)	43.32
Beta	-1.23
Rel Volume	1.94
Avg Volume	5.03M
Volume	9,748,872

Perf Week	-4.37%
Perf Month	-2.98%
Perf Quarter	-26.41%
Perf Half Y	-8.75%
Perf YTD	-23.67%
Perf Year	-49.53%
Perf 3Y	574.24%
Perf 5Y	68.56%
Perf 10Y	100.42%
Recom	1.83
Target Price	28.34
Prev Close	14.00
Price	13.35
Change %	-4.64%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)